oxytetracycline

oxytetracycline is a lipid of Polyketides (PK) class. Oxytetracycline is associated with abnormalities such as Infection, X-linked centronuclear myopathy, Bacterial Infections, Heart failure and Onchocerciasis. The involved functions are known as Anabolism, physiological aspects, Transcription, Genetic, Fermentation and Transcriptional Activation. Oxytetracycline often locates in Chromosomes, Flank (surface region), Entire bony skeleton, Bone Marrow and Body tissue. The associated genes with oxytetracycline are Polypeptides, Homologous Gene, Gene Clusters, Locus and CYCS gene. The related lipids are LH 1 and Lipid Peroxides. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of oxytetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with oxytetracycline?

oxytetracycline is suspected in Infection, Helminthiasis, Nodule, Bacterial Infections, Yeast infection, pathologic fistula and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with oxytetracycline

MeSH term MeSH ID Detail
Swine Diseases D013553 16 associated lipids
Cardiac Tamponade D002305 7 associated lipids
Poultry Diseases D011201 21 associated lipids
Anemia D000740 21 associated lipids
Respiratory Tract Diseases D012140 4 associated lipids
Hemorrhagic Disorders D006474 3 associated lipids
Hypertrophy D006984 16 associated lipids
Carcinoma 256, Walker D002279 22 associated lipids
Esophageal Stenosis D004940 2 associated lipids
Bronchopneumonia D001996 7 associated lipids
Per page 10 20 50 100 | Total 137

PubChem Associated disorders and diseases

What pathways are associated with oxytetracycline

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with oxytetracycline?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with oxytetracycline?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with oxytetracycline?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with oxytetracycline?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with oxytetracycline?

Disease model

Disease model are used in the study 'A molecular ecological approach to the detection and designation of the etiological agents of a model polymicrobial disease.' (Antiabong JF et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with oxytetracycline

Download all related citations
Per page 10 20 50 100 | Total 5138
Authors Title Published Journal PubMed Link
NIEDELMAN ML et al. Terramycin in the treatment of chancroid, lymphogranuloma venereum, and granuloma inguinale. 1951 Am J Syph Gonorrhea Vener Dis pmid:14878094
JANBON M et al. [Brucellosis therapy by terramycin]. 1951 Concours Med pmid:14887196
MASON R et al. Serum levels after oral administration of terramycin base. 1951 J Am Pharm Assoc Am Pharm Assoc pmid:14907467
SHWACHMAN H Progress in the study of "mucoviscidosis" (pancreatic fibrosis); with illustrative case presentations. 1951 Pediatrics pmid:14827615
RAVINA A et al. [Two cases of endocarditis lenta treated with terramycin]. 1951 Apr 6-13 Bull Mem Soc Med Hop Paris pmid:14848660
GIUNCHI G [Terramycin in the treatment of human brucellosis]. 1951 Jan 20-27 Clin Nuova Rass Prog Med Int pmid:14839803
AGOSIN M et al. [Attempts of chemotherapy in experimental Chagas' disease. V. Terramycin]. 1951 Jan-Mar Bol Inf Parasit Chil pmid:14821013
SEREMBE M [Fluorescence of terramycin; fluorometric titration]. 1951 Jul-Aug Boll. Soc. Ital. Biol. Sper. pmid:14904695
CROSNIER R et al. [Preliminary observations on terramycin in therapy of acute intestinal amebiasis]. 1951 Jun 15-22 Bull Mem Soc Med Hop Paris pmid:14859132
FEROLA R [Terramycin]. 1951 Mar-Apr Pediatria (Napoli) pmid:14853600
BILLIOTTET J and EZANNO J [Case of endocarditis lenta, resistant to average doses of penicillin; success with terramycin]. 1951 May 4-11 Bull Mem Soc Med Hop Paris pmid:14859094
SANTI R and SEREMBE M [Circulation of terramycin in the animal organism with special reference to its relations with the lymph]. 1951 May-Jun Boll Ist Sieroter Milan pmid:14869444
MEYER DE SCHMID JJ et al. [Terramycin in dermatology]. 1951 Nov-Dec Bull Soc Fr Dermatol Syphiligr pmid:14925763
MAINIERO D [Terramycin in surgical diseases; clinical and bacteriologic study]. 1951 Sep-Oct Athena pmid:14895447
CAFFERY EL et al. Levels of terramycin in the serum after administration of terramycin base. 1952 Antibiot Chemother (Northfield) pmid:24541794
ARMSTRONG WW et al. Terramycin Intravenous. 1952 J Am Pharm Assoc Am Pharm Assoc pmid:14907480
[Terramycin in the treatment of venereal diseases]. 1952 Med Hyg (Geneve) pmid:14909743
EUFINGER H [Effects of terramycin and chloromycetin on bacteria causing urinary infection]. 1952 Z Urol pmid:12995900
BATEMAN JC et al. Fatal complications of intensive antibiotic therapy in patients with neoplastic disease. 1952 AMA Arch Intern Med pmid:12996105
LAZARUS JA and WOOD WA Permanence of effects of modern chemotherapeutic and antibiotic agents in urinary tract infections, with special reference to terramycin in resistant conditions. 1952 Am Pract Dig Treat pmid:14933729